At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Sep 10, 2026 at 06:40 ET
ResMed's CEO and a director sold a combined ~$1.34M in shares over a week, with the CEO's sale following a derivative exercise. While the dollar amount is trivial relative to the $31.9B market cap (0.004%), the cluster involves the Chairman/CEO and a director, and the CEO's sale was an open-market disposition after a cashless exercise. The cluster is notable but not material enough to drive a bearish call on its own.
- CEO Michael J. Farrell sold 4,991 shares at $222.44 for ~$1.11M on 2026-09-08, following a derivative exercise of the same number of shares.
- Director Peter C. Farrell sold 970 shares at $234.73 for ~$228K on 2026-09-02.
- Total cluster value is ~$1.34M, representing ~0.004% of ResMed's $31.9B market cap, well below the 0.1% materiality threshold.
- The CEO's sale was an open-market transaction (code S) after a non-cash derivative exercise (code M), a common pattern for tax withholding or diversification.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access